Number of Shares
1.70 Mil
Current Holdings Value*
$19.61 Mil
% of Portfolio
4.01%
Total Estimate Gain
$9.12 Mil
% of Total Estimate Gain
37.41%

SILVERARC CAPITAL MANAGEMENT, LLC's KalVista Pharmaceuticals Inc Holding Summary

As of 2025-03-31, SILVERARC CAPITAL MANAGEMENT, LLC held 1.70 Mil shares of KalVista Pharmaceuticals Inc(KALV), totaling $19.61 Mil. This investment constitutes 4.01% of their stock portfolio, and SILVERARC CAPITAL MANAGEMENT, LLC now holds 3.42% of the outstanding KalVista Pharmaceuticals Inc(KALV) stock.

The initial trade took place in 2021Q1. And since then SILVERARC CAPITAL MANAGEMENT, LLC has made 6 purchases of KALV, at an average price of $10.32, for a total of 2.36 Mil shares. In addition, there have been 6 sales at an average price of $11.09 for 662,110.00 shares. Based on historical transaction data and KALV's current price of $15.39, SILVERARC CAPITAL MANAGEMENT, LLC's estimated gain on his KALV holdings is $9.12 Mil, reflecting a 37.41% gain to date.

SILVERARC CAPITAL MANAGEMENT, LLC KALV ($15.39) Holding Chart

SILVERARC CAPITAL MANAGEMENT, LLC KALV ($15.39) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1